NDC 50066-121

Advanced Anti-Wrinkle Therapy Cicatricure

Avobenxone 3%, Octinoxate 7.5%, Octisalate 5%, Octocrylene 2.7%, Oxybenzone 4%

Advanced Anti-Wrinkle Therapy Cicatricure is a Topical Cream in the Human Otc Drug category. It is labeled and distributed by Genomma Lab. The primary component is Avobenzone; Octinoxate; Octisalate; Octocrylene; Oxybenzone.

Product ID50066-121_7f962f4d-4050-735a-e053-2a91aa0af65c
NDC50066-121
Product TypeHuman Otc Drug
Proprietary NameAdvanced Anti-Wrinkle Therapy Cicatricure
Generic NameAvobenxone 3%, Octinoxate 7.5%, Octisalate 5%, Octocrylene 2.7%, Oxybenzone 4%
Dosage FormCream
Route of AdministrationTOPICAL
Marketing Start Date2019-01-21
Marketing CategoryOTC MONOGRAPH NOT FINAL / OTC MONOGRAPH NOT FINAL
Application Numberpart352
Labeler NameGenomma Lab
Substance NameAVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE
Active Ingredient Strength3 g/100g; g/100g; g/100g; g/100g; g/100g
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 50066-121-01

1 TUBE in 1 CARTON (50066-121-01) > 42 g in 1 TUBE
Marketing Start Date2019-01-21
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 50066-121-01 [50066012101]

Advanced Anti-Wrinkle Therapy Cicatricure CREAM
Marketing CategoryOTC monograph not final
Application Numberpart352
Product TypeHUMAN OTC DRUG
Marketing Start Date2019-01-21

Drug Details

Active Ingredients

IngredientStrength
AVOBENZONE3 g/100g

OpenFDA Data

SPL SET ID:7f95544e-c6b8-cd1a-e053-2991aa0ac867
Manufacturer
UNII

NDC Crossover Matching brand name "Advanced Anti-Wrinkle Therapy Cicatricure" or generic name "Avobenxone 3%, Octinoxate 7.5%, Octisalate 5%, Octocrylene 2.7%, Oxybenzone 4%"

NDCBrand NameGeneric Name
50066-033Advanced Anti-Wrinkle Therapy CicatricureAdvanced Anti-Wrinkle Therapy Cicatricure
50066-021Advanced Anti-Wrinkle TherapyAvobenxone 3%, Octinoxate 7.5%, Octisalate 5%, Octocrylene 2.7%, Oxybenzone 4%
50066-121Advanced Anti-Wrinkle TherapyAvobenxone 3%, Octinoxate 7.5%, Octisalate 5%, Octocrylene 2.7%, Oxybenzone 4%

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.